🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07842757
Starting soon Observational

Preoperative Gastric Volume and High-Risk Gastric Content in Patients With Type 2 Diabetes Mellitus

NCT07842757 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-10-01
Last updated
2026-09-25

Condition(s) studied

Type 2 Diabetes Mellitus (DM)Gastric Ultrasound

Investigational drug(s) / intervention(s)

Preoperative Gastric UltrasonographyCapillary Fasting Blood Glucose Measurement

Preoperative Gastric Ultrasonography: The gastric antrum will be evaluated in the supine and right lateral decubitus positions before anesthesia induction and sedative premedication. Gastric contents will be assessed qualitatively, and antral cross-sectional area and estimated residual gastric volume will be calculated quantitatively.

Capillary Fasting Blood Glucose Measurement: Capillary fasting blood glucose will be measured by fingertip sampling immediately before gastric ultrasonography. The measured glucose concentration will be evaluated as the primary exposure variable in relation to high-risk gastric findings.

Study summary

This prospective observational study will evaluate adult patients with type 2 diabetes mellitus who are scheduled for elective surgery. Immediately before preoperative gastric ultrasonography, capillary fasting blood glucose will be measured.

Gastric contents will be assessed qualitatively in the supine and right lateral decubitus positions, and residual gastric volume will be estimated using the antral cross-sectional area measured in the right lateral decubitus position.

The primary objective is to evaluate the association between fasting capillary blood glucose and the presence of a high-risk stomach. A high-risk stomach will be defined as the presence of solid gastric contents, Perlas Grade 2 gastric contents, or an estimated gastric volume greater than 1.5 mL/kg.

Secondary objectives include determining the prevalence of a high-risk stomach and evaluating its associations with demographic characteristics, diabetes-related factors, comorbidities, fasting duration, medication use, gastroparesis-related symptoms, and routine laboratory parameters.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older * Diagnosis of type 2 diabetes mellitus * American Society of Anesthesiologists (ASA) physical status II or III * Scheduled for elective surgery * Suitable for preoperative gastric ultrasonography * Provision of written informed consent Exclusion Criteria: * Pregnancy * Body mass index ≥40 kg/m² * Emergency surgery * History of gastric, esophageal, or upper gastrointestinal surgery * Presence of a nasogastric tube * Known gastroparesis or gastric outlet obstruction * Active vomiting * Systemic opioid or prokinetic drug use within the previous 72 hours * Anatomical or technical conditions preventing adequate gastric ultrasonographic assessment * Impaired consciousness or inability to provide a reliable medical history * Refusal to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bakırköy Dr. Sadi Konuk Training and Research Hospital Istanbul Istanbul

More Bakirkoy Dr. Sadi Konuk Research and Training Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07842757 on ClinicalTrials.gov ↗ ← All trials in Turkey